Investor name:
Christopher Fuglesang
Investor type:
Locations:
Social media:
Available after registration.Past investments:
- Black Diamond Therapeutics
- AveXis
- Aligos Therapeutics
- Tyra Biosciences
- Encoded Therapeutics
- Nabriva Therapeutics
- Cullinan Oncology
- Silverback Therapeutics
- Telesta Therapeutics
- Prevail Therapeutics
- Nuvation Bio
- Scorpion Therapeutics
- PMV Pharmaceuticals
- Cabaletta Bio
- Attune Pharmaceuticals
- Pandion Therapeutics
- CiVi Biopharma
- GTx
- Vividion Therapeutics
- Akero Therapeutics
- Codiak Biosciences
- Elevation Oncology
- Atreca
- Asher Bio
- Sojournix
- Cedilla Therapeutics
- G1 Therapeutics
- Shoreline Biosciences
- Solid Biosciences
- Milestone Pharmaceuticals
- Passage Bio
- Centessa Pharmaceuticals
- Biomea Fusion
- BioAtla
- Poseida Therapeutics
- MEI Pharma
- Achilles Therapeutics
- Kinnate Biopharma
- Day One Biopharmaceuticals
- Revolution Medicines
- Boundless Bio
- Rain Therapeutics
- IDEAYA Biosciences
- Mereo Biopharma
- ITeos Therapeutics
- Nurix Therapeutics
- Syndax Pharmaceuticals
- Tango Therapeutics
- Connect Biopharmaceuticals
- Vivace Therapeutics
Finally raise your round with Angel Match
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today